LIVER FUNCTION IN CHLORPROPAMIDE THERAPY. FIVE YEAR CLINICAL STUDY OF 181 PATIENTS.
D000380:Agranulocytosis; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase / Q000097:blood*; D001219:Aspartate Aminotransferases; D035843:Biomedical Research; D001797:Blood Protein Electrophoresis; D056486:Chemical and Drug Induced Liver Injury; D002747:Chlorpropamide; D004796:Clinical Enzyme Tests; D003920:Diabetes Mellitus; D006452:Hemoglobinometry; D006505:Hepatitis; D007328:Insulin; D007958:Leukocyte Count; D008111:Liver Function Tests; D014116:Toxicology
D007328:Insulin; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D002747:Chlorpropamide
AGRANULOCYTOSIS; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BLOOD ALKALINE PHOSPHATASE; BLOOD PROTEIN ELECTROPHORESIS; CHLORPROPAMIDE; CLINICAL RESEARCH; DIABETES MELLITUS; ENZYME TESTS; HEMOGLOBINOMETRY; HEPATITIS, TOXIC; INSULIN; LEUKOCYTE COUNT; LIVER FUNCTION TESTS; TOXICOLOGIC REPORT